Octreotide in gastrointestinal motility disorders

45Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

The effects of octreotide on six normal subjects and five patients with scleroderma were investigated. Changes in intestinal motility and in plasma motilin were exmined after a single injection of octreotide. Octreotide stimulated intense intestinal motor activity in normal subjects. Motility patterns in the scleroderma patients were chaotic and non-propagative, but, after octreotide was given, became well coordinated, aborally directed, and nearly as intense as in normal volunteers. Clinical responses and changes in breath hydrogen were also evaluated in the five scleroderma patients who had further treatment with octreotide at a dose of 50 μg/day subcutaneously for three weeks. A reduction in symptoms of abdominal pain, nausea, vomiting, and bloating was seen. Additionally, there was an improvement in bacterial overgrowth as objectively measured by breath hydrogen testing. The effects of octreotide (100 μg/day subcutaneously) on the perception of rectal distension were investigated in a double blind, placebo controlled study in healthy volunteers. Octreotide was shown to reduce the perception of rectal distension without affecting motor pathways or local rectal reflexs. This enhanced tolerance to volume distension seems to resul from inhibition of sensory afferent pathways as shown by electroencephalographic studies showing diminished evoked spinal and cortical potentials after octreotide. In irritable bowel syndrome patients with rectal urgency, octreotide reduces rectal pressures and perception after rectal distension to near normal values.

References Powered by Scopus

Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence

708Citations
N/AReaders
Get full text

Tolerance for rectosigmoid distention in irritable bowel syndrome

593Citations
N/AReaders
Get full text

Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma

391Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Principles of applied neurogastroenterology: Physiology/motility- sensation

117Citations
N/AReaders
Get full text

Gastrointestinal manifestations of systemic sclerosis

112Citations
N/AReaders
Get full text

Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases

90Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Owyang, C. (1994). Octreotide in gastrointestinal motility disorders. Gut. BMJ Publishing Group. https://doi.org/10.1136/gut.35.3_suppl.s11

Readers over time

‘12‘13‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

64%

Researcher 6

24%

Professor / Associate Prof. 3

12%

Readers' Discipline

Tooltip

Medicine and Dentistry 25

81%

Nursing and Health Professions 3

10%

Agricultural and Biological Sciences 2

6%

Psychology 1

3%

Save time finding and organizing research with Mendeley

Sign up for free
0